Bristol Myers Squibb adds $1 million community grant programme to second year of Champions in Care campaign

Bristol Myers Squibb has widened its Champions in Care initiative, which honours healthcare professionals, as the campaign enters its second year after launching in 2025. The first year celebrated healthcare professionals across a range of therapy areas through digital, social and live events. The latest phase gives them new ways to make a difference beyond the clinic, in the communities they serve.

As part of the expansion, the company will award $1 million in grants to nonprofit organisations that support medically underserved communities across the United States. Candidates for the grants will be put forward through an anonymous nomination process aimed at recognising groups that help close gaps in care. Bristol Myers Squibb is inviting nominations from healthcare professionals, who it says are well placed to understand the most pressing needs in their communities and the obstacles patients face in getting care.

Adam Lenkowsky, executive vice president and chief commercialisation officer at Bristol Myers Squibb, said the campaign began last year as a way to recognise the extraordinary impact healthcare professionals have on patients, families and communities. He said the company is now building on that foundation by letting them acknowledge the organisations that support the underserved communities they work with.

Details of the nomination process and criteria are available on the company’s website, and nominations close on 30 November 2026. A nomination does not guarantee funding. Nominated organisations may be invited to apply for a grant and will go through a separate review and selection process before any awards are made.

Over the rest of the year, Bristol Myers Squibb will carry Champions in Care forward through further social, digital and live activities at medical meetings, celebrating healthcare professionals and highlighting what they contribute to patients and communities around the world.

---

---

Related Topics and Keywords

Bristol-Myers Squibb